Physicians at Rambam Health Care Campus in Haifa used focused ultrasound to eliminate a man’s opioid addiction in a single 20-minute session. His craving score dropped to zero. One week later he tested clean. He also, almost incidentally, stopped smoking three packs a day and lost his desire for alcohol. The treatment did not target his nicotine addiction or his drinking. It appeared to reset the entire reward system.
That is not a misprint. And it is not a one-off anecdote — it is one of the more dramatic results to emerge from a peer-reviewed clinical program that has been accumulating evidence for years.
I spent 20 years working inside hospital systems. I have watched technologies move from case report to standard of care, and I have watched promising interventions stall out in the evidence pipeline. This one is moving. Here is what the research actually shows, what the technology does, and what it means for people who are not candidates for a focused ultrasound procedure.
The Published Research Behind the Rambam Case
The Rambam treatment was not a one-off experiment. It was conducted as part of an international clinical program studying low-intensity focused ultrasound (LIFU) targeting the nucleus accumbens — the brain region central to reward, pleasure, and addictive behavior.
The foundational peer-reviewed paper, published in Frontiers in Psychiatry (2023), documented a safety and feasibility clinical trial of this exact approach. The trial found that bilateral nucleus accumbens LIFU neuromodulation was safe, well-tolerated, and produced a mean 91% decrease in opioid craving that extended to 90 days post-procedure. MRI scans showed no structural brain changes. No surgery. No anesthesia. No recovery period.
A companion first-in-human report (PubMed PMID 37610405) established the initial safety profile that made the expanded Rambam trial possible.
The technology — Insightec’s ExAblate Neuro system — uses MRI-guided ultrasound to deliver precise energy to a structure the size of a cherry inside the skull. It is the same platform used in FDA-cleared treatments for essential tremor and Parkinson’s tremor. The opioid addiction indication is still investigational, but the underlying technology has an established clinical track record.
Why Sound Can Do What Surgery Cannot
Most people think of sound as something passive — music in the background, noise that helps them sleep. The biology tells a different story.
Sound is a physical force. At sufficient intensity and with sufficient precision, it acts directly on tissue. The Insightec system used at Rambam concentrates ultrasound energy to a point accurate enough to target a specific brain nucleus without opening the skull or damaging surrounding tissue. It modulates electrical activity in neurons — not by destroying cells, but by altering their firing patterns.
That mechanism — sound changing how neurons fire — is not unique to high-intensity clinical systems. It is the same principle operating at the consumer end of sound therapy, at several orders of magnitude lower intensity.
The Rambam case does not mean that listening to brown noise will cure addiction. What it confirms is that the brain’s reward and regulation systems respond to external acoustic input. They are not fixed. They can be moved. The clinical question is what kind of input, at what intensity, produces which effects.
The Spectrum: From Focused Ultrasound to Consumer Sound Therapy
High-intensity focused ultrasound is the extreme end of a spectrum. At the consumer end are the forms of sound therapy that researchers have been studying in sleep labs and clinical settings for two decades.
40Hz gamma frequencies. In 2016, neuroscientist Li-Huei Tsai at MIT published findings that 40Hz light and sound stimulation reduced amyloid plaques in the brains of mice — the same plaques associated with Alzheimer’s disease. Her lab has since moved into human trials, with multiple institutions now running clinical studies on gamma entrainment and cognitive protection. The proposed mechanism: gamma oscillations drive microglia — the brain’s immune cells — to clear metabolic waste more efficiently.
Pink noise and deep sleep. A 2017 Northwestern University study published in Frontiers in Human Neuroscience found that pink noise synchronized to slow-wave sleep oscillations improved memory consolidation in older adults. Slow-wave sleep is the stage where the brain clears beta-amyloid — the same protein that accumulates in Alzheimer’s disease.
Brown and white noise for attention. A 2021 meta-analysis in PLOS One reviewed 29 studies on noise and cognition. It found moderate evidence that background noise improves attention, working memory, and reading performance in individuals with ADHD. The proposed mechanism is stochastic resonance — a counterintuitive phenomenon where adding low-level noise to a signal can make the signal clearer.
Binaural beats and brainwave entrainment. The brain synchronizes to rhythmic auditory input — a phenomenon called neural entrainment. A 2019 review in Psychological Research found binaural beat stimulation produced measurable changes in mood and cognitive performance consistent with the target frequency.
What This Means as a Daily Practice
The research does not support the idea that a single listening session produces lasting change. What the studies consistently show is that effects require regular, intentional exposure over time. The brain is frequency-sensitive, and the frequencies it receives shape how it operates — but the effect is cumulative, not immediate.
The practical implication: frequency exposure is a daily practice, not an event. The same way cardiovascular fitness requires consistent training, the neurological benefits of intentional sound exposure appear to require consistent application.
The Rambam case used clinical-grade equipment at clinical intensity to produce a dramatic immediate result. Consumer sound therapy operates on the same underlying principle at a fraction of the intensity — which means the timeline for results is longer and the effect sizes are smaller, but the mechanism is real and the research base is growing.
Content on this site is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before making changes to your health protocols.
Disclosure: The author has a financial interest in sound therapy applications including 40Hz Gamma: Focus & Memory, ADHD Brown Noise Focus, Isochronic Tones, and Breathing Timer. Links to these applications may appear in related articles on this site.
Sources:
— Frontiers in Psychiatry (2023): Low-intensity focused ultrasound targeting the nucleus accumbens — safety and feasibility clinical trial. PMC10540197.
— PubMed PMID 37610405: First-in-human report — LIFU targeting bilateral nucleus accumbens for substance use disorder.
— Tsai, L.H. et al. (2016). Gamma frequency entrainment attenuates amyloid load and modifies microglia. Nature.
— Frontiers in Human Neuroscience (2017): Pink noise and slow-wave sleep memory consolidation.
— PLOS One (2021): Background noise and cognitive performance meta-analysis — 29 studies.
— Psychological Research (2019): Binaural beat stimulation effects on mood and cognition.
